Merck to pay Gilead $14m in attorneys’ fees
20-07-2017
Judge overturns $200m award in Gilead v Merck
09-06-2016
Merck handed $200m in Gilead hepatitis C row
29-03-2016
Merck claims hepatitis C patent win
23-03-2016
Gil C / Shutterstock.com
A judge assessing a patent dispute between Merck and Gilead centring on hepatitis C treatments has allowed Gilead to submit new evidence of jurors allegedly being misled.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Merck, Gilead, hepatitis C, patent infringement, damages, patent, Harvoni, Sovaldi, US District Court for the Northern District of California
